BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 174 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2019. The put-call ratio across all filers is 0.44 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $146,000 | -38.1% | 967 | -40.4% | 0.01% | -44.4% |
| Q2 2022 | $236,000 | +18.0% | 1,622 | -4.0% | 0.01% | +28.6% |
| Q1 2022 | $200,000 | +70.9% | 1,690 | +39.8% | 0.01% | +75.0% |
| Q2 2021 | $117,000 | +60.3% | 1,209 | +20.7% | 0.00% | -50.0% |
| Q2 2020 | $73,000 | -65.9% | 1,002 | -79.5% | 0.01% | -86.4% |
| Q2 2019 | $214,000 | +39.9% | 4,883 | +64.3% | 0.06% | -1.7% |
| Q1 2019 | $153,000 | +183.3% | 2,972 | +103.4% | 0.06% | +140.0% |
| Q4 2018 | $54,000 | +285.7% | 1,461 | +279.5% | 0.02% | +400.0% |
| Q3 2018 | $14,000 | -56.2% | 385 | -67.6% | 0.01% | -79.2% |
| Q4 2017 | $32,000 | +540.0% | 1,187 | +534.8% | 0.02% | +380.0% |
| Q2 2017 | $5,000 | – | 187 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 1,111,111 | $154,344,000 | 72.03% |
| Knoll Capital Management, LLC | 856,844 | $119,024,000 | 59.36% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,124,055 | $295,053,000 | 36.73% |
| ARS Investment Partners, LLC | 466,668 | $64,825,000 | 6.49% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 365,373 | $50,754,000 | 6.18% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $24,490,000 | 5.91% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 61,897 | $8,598,000 | 4.86% |
| DAFNA Capital Management LLC | 88,100 | $12,238,000 | 3.25% |
| Avidity Partners Management LP | 934,200 | $129,770,000 | 2.88% |
| Eventide Asset Management | 1,325,000 | $184,056,000 | 2.43% |